AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2016

Apr 4, 2016

33819_dirs_2016-04-04_32df312d-b1b9-4d3f-8337-bbbccd8862d5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2016-04-01

Reporting Person: WEISSMAN IRVING (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-01	Common Stock	A	48077	$0.00	Acquired	558288	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	22471	Indirect

Footnotes

F1: Quarterly retainer paid to Dr. Weissman in shares of common stock as consideration for his continued service on the Company's Scientific Advisory Board.

F2: Includes the following anniversary equity grant: 146,342 restricted stock units vesting 100% on January 1, 2017.

F3: Includes 10,508 shares held in trust for Dr. Weissman's grandchildren. Dr. Weissman disclaims beneficial ownership of such shares.